NFKB1 and chronic obstructive pulmonary disease: Although the mechanism is not fully clarified, previous studies have reported that NF-κB can be activated in the lungs and inflammatory cells, particularly in alveolar macrophages and airway epithelial cells of COPD patients [10, 24].